MIR326, microRNA 326, 442900

N. diseases: 95; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.070 Biomarker disease BEFREE Our findings suggest that miR-326 may be a candidate prognostic biomarker and a target for new therapies in HCC patients. 31298047 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.070 Biomarker disease BEFREE Meanwhile, miR-326 mimics can also inhibit HCC progression, whereas miR-326 inhibitors exhibited a reverse phenomenon by modulating H19 expression. 30362512 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.070 Biomarker disease BEFREE Mechanism studies showed that circASAP1 acts as a competing endogenous RNA (ceRNA) for miR-326 and miR-532-5p, both of which are tumor suppressors in HCC. 31838741 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.070 AlteredExpression disease BEFREE In the present study, by analyzing 47 tissue specimens of human HCC, we found that the relative expression levels of SNHG3 were significantly higher in HCC tissues than those in the adjacent noncancerous tissues, whereas the relative expression levels of miR-326 were significantly lower in HCC tissues. 31548493 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.070 Biomarker disease BEFREE MiR-424, miR-326 and miR-511 could be applied for HCC diagnostic biomarkers. 28060739 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.070 Biomarker disease BEFREE In addition, LIM and SH3 protein 1 (LASP1) was identified as a direct target gene of miR-326 in HCC. 28713953 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.070 Biomarker disease BEFREE MicroRNA‑133a and microRNA‑326 co‑contribute to hepatocellular carcinoma 5‑fluorouracil and cisplatin sensitivity by directly targeting B‑cell lymphoma‑extra large. 26239225 2015